TP53 and breast cancer: We have recently reported a mammary gland targeted Aurora-A mouse model in a p53 wild-type background in which Aurora-A expression is driven by ovine β-lactoglobulin promoter led to the development of mammary tumors after four to five of pregnancy cycles (95).